Doctors Celebrate Breakthrough Cancer Treatment with Standing Ovationhttps://hotair.com/john-s-2/2026/06/01/doctors-celebrate-breakthrough-cancer-treatment-with-standing-ovation-n3815502... This weekend a large group of oncologists, doctors who specialize in the treatment of cancer, met to show off their latest breakthroughs at a conference called ASCO26. The news from this conference is so good that it brought standing ovations from the assembled doctors.
The big breakthrough that everyone is excited about involves pancreatic cancer which has long been a death sentence for many people. For instance, cartoonist Scott Adams died from metastatic prostrate cancer earlier this year. But a new drug called daraxonrasib seems to dramatically extend the life of those treated with it. The NY Times wrote about it last month.
A drug nearing regulatory approval, daraxonrasib, is the first to substantially extend the lives of patients with pancreatic cancer. It works by targeting a cellular protein that fuels not just nearly all pancreatic tumors, but also many lung and colon cancers. Those three are the leading causes of cancer deaths.
...
The drug that opened the floodgates, daraxonrasib, has been fast-tracked for review by the Food and Drug Administration and could win approval later this year. Until then, the agency has signed off on a plan by Revolution Medicines, the small Silicon Valley company developing the drug, to offer early access to some patients.
The pills, three taken daily, are not a cure — eventually, daraxonrasib stops working. Many patients do not respond. And it has side effects that can be harsh, including rash, diarrhea, fatigue, nausea and raw, split fingertips.
...
Again, it's not a cure, but a cancer that was considered unbeatable has been shown to have a weakness. The drug works by turning off the gene that causes the disease to run rampant.
The current survival rate for pancreatic cancer is about 1 in 8. This drug sounds like it slows the progression rather than bringing remission so it won't necessarily change that. It may, however, extend some people's lives so they may be around to benefit from future progress.